May 7 (SeeNews) - Bosnian pharmaceuticals producer Bosnalijek [SAJ:BSNLR] said it booked a net loss of 4.9 million marka ($2.7 million/2.5 million euro) in the first quarter of the year, compared with a net loss of 7.2 million marka recorded in the like period a year earlier.
Total revenue went up 33% year-on-year to 26.6 million marka, whereas total expenses rose 15.8% to 31.6 million marka in the January-March period, Bosnalijek said in a filing to the Sarajevo Stock Exchange (SASE) on Monday.
The company's shares last traded on SASE on April 24, closing 0.19% lower at 21.01 marka.
Bosnalijek is the largest pharmaceuticals company in Bosnia and Herzegovina.
(1 euro = 1.956 marka)